Olmesartan Medoxomil-HCTZ

Browse eMedTV's wide range of articles related to olmesartan medoxomil-hctz including topics such as generic olmesartan medoxomil-hydrochlorothiazide, olmesartan medoxomil-hydrochlorothiazide dosing, and side effects of olmesartan medoxomil-hydrochlorothiazide. Use the search box at the top-right corner of the page to find information about other health topics.

Description of Articles in Olmesartan Medoxomil-HCTZ

This eMedTV resource explains that olmesartan medoxomil-hydrochlorothiazide is a prescribed medication used to lower high blood pressure in adults. This resource also explores how the medication works, its uses, and potential side effects.

As this eMedTV article explains, many side effects of olmesartan medoxomil-hydrochlorothiazide are minor and easily treated, such as dizziness and nausea. This article also covers some of the more severe and rare side effects of the medication.

What is olmesartan medoxomil-hydrochlorothiazide used for? As this eMedTV page explains, this combination medicine is used to lower high blood pressure in adults by relaxing the blood vessels and removing more water from the blood.

This eMedTV segment explains that, initially, the olmesartan medoxomil-hydrochlorothiazide dosing requirement for most people with high blood pressure is 20 mg/12.5 mg once a day. This page also offers guidelines for how to take the drug.

This eMedTV page provides information about potential drug interactions with olmesartan medoxomil-hydrochlorothiazide, including interactions with barbiturates, narcotics, and insulin. This page also discusses how these interactions affect the body.

This section of the eMedTV library outlines some of the warnings and precautions with olmesartan medoxomil-hydrochlorothiazide, such as being aware of certain drug interactions. This page also explains who should not take this medication.

This eMedTV article explains why there is currently no generic olmesartan medoxomil-hydrochlorothiazide for sale on the market. This article also explains why the earliest date a generic version of the drug could become available is in 2016.